Apontis Pharma AG
Apontis Pharma AG, a prominent player in the pharmaceutical industry, is headquartered in Düsseldorf, Germany. Founded in 2016, the company has quickly established itself as a leader in developing innovative therapies for patients with complex health conditions, particularly in the fields of neurology and oncology. Apontis Pharma focuses on creating unique, patient-centric solutions that address unmet medical needs, leveraging advanced drug delivery systems and proprietary technologies. With a commitment to enhancing treatment outcomes, the company has achieved significant milestones, including strategic partnerships and successful clinical trials. Recognised for its dedication to research and development, Apontis Pharma AG continues to strengthen its market position, aiming to improve the lives of patients across Europe and beyond.
DitchCarbon Score
How does Apontis Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Apontis Pharma AG's score of 22 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Apontis Pharma AG's reported carbon emissions
Apontis Pharma AG, headquartered in Germany, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This trend often includes setting science-based targets for emissions reductions and implementing initiatives to enhance energy efficiency and reduce overall carbon footprints. As Apontis Pharma AG continues to navigate the evolving landscape of corporate responsibility, it may consider establishing measurable climate commitments in line with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Apontis Pharma AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
